In this study, we embarked upon a phenotypic screening strategy to identify small molecules that could sensitise a SAMHD1‐proficient AML cell line to ara‐C but not their SAMHD1‐deficient counterpart. This evidence concerns the gene SAMHD1 and acute myeloid leukemia.